Clarivant Health Intelligence / About

Analyst-led intelligence for healthcare decision-makers

Clarivant Health Intelligence produces primary-research-grounded market intelligence for pharmaceutical, medical device, diagnostics, biotech, digital health, and healthcare investment teams.

Reports Published 1,000+ Healthcare and life sciences titles
Sectors Covered 10 Across the care continuum
Research Model Primary No syndicated data dependency
Clinical Use None Business and investment only
!
Not for clinical use
Clarivant Health Intelligence content is produced for market intelligence, business strategy, investment research, and commercial decision-making purposes only. It is not medical advice, clinical guidance, or a substitute for professional healthcare decisions.
Our Mission

What Clarivant Health is built to do

To give the professionals who build, fund, and manage healthcare businesses the same quality of intelligence that regulators and large-cap pharma companies apply to their own decisions.

Healthcare strategy, licensing, M&A, and investment decisions are often made against incomplete information. Therapy area sizing estimates differ by multiples across sources. Competitive pipeline analyses miss approved products. Due diligence work frequently traces back to the same syndicated market estimates.

Clarivant Health Intelligence addresses that gap by anchoring analysis in verified evidence: company revenue disclosures, FDA clearance data, CMS reimbursement filings, regulatory submissions, clinical trial registrations, and interviews with analysts who track these markets full time.

What We Are Not

How we differ from market research firms

Clarivant Health Intelligence is not a conventional market research publisher. We do not aggregate and repackage syndicated data from third-party research firms. We do not publish reports in 48 hours. We do not generate market size figures from unverified regression models.

We are a healthcare intelligence platform. Our reports take longer to produce because they are built from primary evidence and analyst review, not from recycled estimates. The result is analysis designed for strategy teams, investment committees, BD groups, and procurement leaders who need defensible decision support.

What Makes Us Different

A higher evidence standard for healthcare intelligence

01
Primary research first
Every report starts with company disclosures, regulatory databases, clinical registries, reimbursement documents, and analyst interviews.
02
Source every number
Market size figures, competitive shares, pipeline counts, and pricing assumptions are traceable to named evidence.
03
Analyst ownership
Reports are owned by sector analysts, not generalist writers assembling healthcare summaries.
04
Not for clinical use
Our content is framed for business, strategy, and investment decisions only. This constraint shapes every report.
05
Intelligence, not commodity research
We focus on decision-grade analysis, evidence quality, and commercial implications rather than volume publishing.
06
Confidentiality by default
Client identities, custom briefs, and NDA-covered discussions are treated as confidential by default.
Sector Coverage

Healthcare and life sciences sectors we cover

Pharmaceuticals
Pharma and Drug Delivery
  • Branded drug market sizing
  • Generics and biosimilars
  • Drug delivery systems
  • API manufacturing and sourcing
Medical Devices
Medical Devices and Equipment
  • Surgical devices and implantables
  • Capital equipment
  • Cardiovascular and orthopaedic devices
  • Point-of-care technologies
Diagnostics
Diagnostics and IVD
  • In-vitro diagnostics
  • Molecular and genomic testing
  • Diagnostic imaging
  • Laboratory automation
Biotechnology
Oncology and Therapeutics
  • Cell and gene therapy
  • Monoclonal antibodies
  • mRNA platforms
  • CDMO manufacturing capacity
Digital Health
Digital Health and Telehealth
  • Digital therapeutics
  • Remote patient monitoring
  • AI diagnostics
  • Health data platforms
Supply Chain
Healthcare Supply Chain
  • API sourcing
  • Cold chain logistics
  • Supplier concentration risk
  • Medical device distribution
Nutraceuticals
Nutraceuticals and Supplements
  • Functional food ingredients
  • Dietary supplements
  • Sports nutrition
  • Probiotic and prebiotic markets
Animal Health
Animal Health and Veterinary
  • Companion animal therapeutics
  • Livestock vaccines
  • Veterinary diagnostics
  • Animal nutrition
Who We Work With

The professionals Clarivant Health serves

Pharma BD and Licensing Teams
Evaluating therapy area entry, asset value, launch opportunity, and partnership strategy.
PE and VC Investment Teams
Validating management projections, commercial assumptions, and competitive positioning in diligence.
Medtech Strategy Teams
Benchmarking product positioning, addressable markets, reimbursement exposure, and regulatory dynamics.
Management Consultants
Supporting healthcare engagements that require independent market sizing and source-verified analysis.
Procurement and Supply Chain Teams
Mapping API, device, supplier, and CMO concentration risks across healthcare networks.
Investment Banks and M&A Advisers
Sourcing independent market context for healthcare mandates and transaction materials.
Our Methodology

How Clarivant Health produces intelligence

Every report follows a structured methodology designed to make market size figures, competitive share estimates, and forecasts traceable to named evidence rather than modelled assumptions.

Stage 01
Primary source inventory
Annual reports, investor presentations, FDA databases, CMS data, trial registries, and regulatory documents are assembled before analysis begins.
Stage 02
Bottom-up market construction
Market sizes are built from disclosed revenues, procedure volumes, device clearance data, unit pricing, and verifiable demand indicators.
Stage 03
Analyst validation
Key findings are reviewed through structured analyst, procurement, clinician-consultant, and industry executive inputs.
Stage 04
Peer review
A second analyst reviews factual accuracy, source attribution, internal consistency, and not-for-clinical-use framing.
Analyst Team

The analysts behind our intelligence

Medical Devices
Device and Diagnostics Lead
Covers wound care, IVD, surgical robotics, POC devices, reimbursement policy, and FDA clearance dynamics.
Wound CareIVDSurgical Devices
Pharma
Pharma and Biotech Lead
Covers branded drugs, biosimilars, cell and gene therapy, mRNA platforms, CDMO capacity, and payer access.
OncologyBiosimilarsCDMO
Digital Health
Digital Health and Supply Chain Lead
Covers DTx, RPM, AI diagnostics, API sourcing, supplier concentration, and CMO capacity tracking.
Digital HealthAI DxSupply Chain
Consumer Health
Nutraceuticals and Animal Health Lead
Covers functional ingredients, supplements, veterinary diagnostics, animal therapeutics, and claim substantiation.
NutritionVeterinarySupplements
Start with a free report sample
Every Clarivant Health report includes a sample with selected data, methodology, and table of contents. Request a sample or browse the live catalog.
Request a Sample Browse Reports